Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia
Otolaryngology–Head and Neck Surgery · 2026
DOI: 10.1002/ohn.70088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2026. Verfasst von Avraham E Adelman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Telangiectasia, Hereditary Hemorrhagic, Sclerotherapy, Vascular Malformations, Mouth Diseases. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Oral telangiectasias in hereditary hemorrhagic telangiectasia (HHT) can significantly impair quality of life. While sclerotherapy is an established treatment for HHT‐related epistaxis, it is rarely used for oral telangiectasias. We retrospectively reviewed HHT patients who underwent oral sclerotherapy between 2021 and 2024 at a tertiary academic center. Eleven patients (64% female, mean age 61.3 years, 82% ACVRL1 genotype) underwent sclerotherapy using a 1:4 mixture of 3% sodium tetradecyl sulfate and air. Lesions treated included the lip (36%), tongue (36%), hard palate (18%), and gingiva (9%). Presenting symptoms included oral bleeding with eating and dietary limitations. Adverse effects included transient lip swelling (n = 2) and tongue burning (n = 1). At an average follow‐up of 6 months, 10/11 patients with follow‐up data had complete symptomatic and clinical resolution. Our findings suggest that oral sclerotherapy is a safe, effective, and minimally invasive treatment for HHT‐related oral bleeding that clinicians should consider.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head & Neck Surgery, University of Florida, Gainesville, Florida, USA.
- Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Avraham E Adelman
Zitieren
APA
Adelman, A. E., Joshi, A., Gallo, K., Prosser, A., Mathavan, A., Mathavan, A., Ataya, A., & Justice, J. (2026). Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70088
Vancouver
Adelman AE, Joshi A, Gallo K, Prosser A, Mathavan A, Mathavan A, et al. Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70088
BibTeX
@article{Adelman2026,
author = {Adelman, Avraham E and Joshi, Advay and Gallo, Kimberly and Prosser, Aaron and Mathavan, Akash and Mathavan, Akshay and Ataya, Ali and Justice, Jeb},
title = {Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70088}
}
EUVIMED